Details of the Drug

General Information of Drug (ID: DMB4G3E)

• Drug Name: Anti-BCMA CAR-T cell therapy

Indication

Disease Entry	ICD 11	Status	REF
Multiple myeloma	2A83	Phase 1	[1]

• Cross-matching ID: TTD ID: D0O7XA

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)